Home | Welcome to Contract Pharma   
Last Updated Thursday, April 24 2014
Print RSS Feed

Breaking News

Related Searches:
May 6, 2011
Myoderm has been granted a Wholesale Dealer License from the Medicines and Healthcare products Regulatory Agency (MHRA), expanding its position within the European pharmaceutical market.  Read More »
May 6, 2011
Quotient Clinical, a business unit of Quotient Bioresearch, has completed a major expansion of its clinical facilities in Nottingham, UK.   Read More »
May 6, 2011
Mark Dean-Netscher has been appointed chief operating officer of Penn Pharma, effective May 16th.  Read More »
May 6, 2011
Axcan Pharma Holding B.V. and Eurand N.V., have renamed of their combined companies to Aptalis Pharma.   Read More »
May 6, 2011
Todd Kole has been named vice president of Clinical Project Services (CPS) and a member of the Executive Leadership Team at Almac Clinical Technologies.  Read More »
May 5, 2011
INC Research has entered a definitive merger agreement to acquire Kendle International for approximately $232 million in cash.  Read More »
May 5, 2011
Early Development revenues were $224.0 million (+9%).   Read More »
May 5, 2011
SCM Pharma has secured a sterile filling and packaging project with Molteni Therapeutics, a specialty pharmaceutical company based in Italy, for a new drug substance in development for the topical treatment of infected skin lesions using the PhotoDynamic   Read More »
May 5, 2011
Claes Glassell has been appointed chief executive officer of CMC Biologics.  Read More »
May 4, 2011
Pfizer, Wyeth vet to take role over R&D and technology programs  Read More »
May 4, 2011
Beijing Second Pharmaceutical Co., Ltd. (BSPC) has received FDA approval of its ANDA 090752 for Amlodipine Besylate, a generic form of Pfizer’s Norvasc.   Read More »
May 4, 2011
Sales were down 7% in the Preclinical Services (PCS) segment to $112.5 million.  Read More »
May 4, 2011
Contract revenue in the quarter was $42.9 million, up 10%.  Read More »
May 4, 2011
Jeffrey S. Litwin, M.D. has been appointed president and chief executive officer of ERT and a member of the board.  Read More »
May 3, 2011
Akorn, Inc. has entered into an agreement to acquire Advanced Vision Research, Inc. (AVR), an OTC ophthalmic company, for $26 million in cash.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On